Search Login Register

Aggressive Fibromatosis (Desmoid) Summary

Description: A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)

Also Known As: Desmoid; Fibromatosis, Aggressive; Aggressive Fibromatoses; Desmoids; Fibromatoses, Aggressive

Networked: 746 relevant articles (52 outcomes, 85 trials/studies) for this Disease

Key Drugs and Agents for Aggressive Fibromatosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tamoxifen : 10 outcomes 4 studies in 46 results : FDA 12 Generic
  2. imatinib (Gleevec) : 4 outcomes 9 studies in 25 results : FDA 3
  3. meloxicam (Mobic) : 4 outcomes 3 studies in 6 results : FDA 24 Generic
  4. Sulindac (Copal) : 4 outcomes 2 studies in 20 results : FDA 15 Generic
  5. Estrogens (Estrogen) : 3 outcomes in 21 results : FDA 1
  6. Toremifene (Fareston) : 2 outcomes 1 study in 14 results : FDA 1
  7. Interferons : 2 outcomes in 3 results : IBA
  8. Vinblastine (Vinblastine Sulfate) : 1 outcome 4 studies in 16 results : FDA 7
  9. Methotrexate (Mexate) : 1 outcome 4 studies in 15 results : FDA 8 Generic
  10. Doxorubicin (Adriamycin) : 1 outcome 1 study in 15 results : FDA 12 Generic
Show All >>

Diseases Related to Aggressive Fibromatosis

  1. Neoplasms (Cancer)
  2. Aggressive Fibromatosis (Desmoid)
  3. Sarcoma (Soft Tissue Sarcoma)
  4. Retroperitoneal Fibrosis
  5. Rhabdomyosarcoma
Show All >>

Key Therapies for Aggressive Fibromatosis

Efficacy Chart >>
  1. Radiotherapy : 9 outcomes 6 studies in 65 results
  2. Drug Therapy (Chemotherapy) : 8 outcomes 8 studies in 61 results
  3. Colectomy : 2 outcomes 1 study in 44 results
  4. Brachytherapy : 1 outcome 1 study in 8 results
  5. Cryosurgery : 1 outcome 1 study in 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.